#United States #Kessler Topaz #Securities Fraud #Radnor #Hims & Hers

Hims & Hers Health, Inc. Investor Alert: Legal Action Invitation

Investors who purchased securities of Hims & Hers Health, Inc. between August 4, 2025, and July 29, 2026, are urged to take notice of a securities fraud class action lawsuit that could impact their financial interests. This alert serves as a crucial reminder for those affected by misinformation regarding the company's business practices.

Who Are The Parties Involved?

Hims & Hers Health, Inc., a publicly traded company listed on the NYSE under the ticker symbol HIMS, is facing a significant challenge in the form of a legal complaint filed in the Northern District of California. The lawsuit, overseen by Kessler Topaz Meltzer & Check, LLP, alleges serious violations that could have been detrimental to investors during the stated class period.

Allegations Against Hims & Hers

The class action's core allegations revolve around deceptive practices and the sharing of sensitive consumer information without proper consent. Some key accusations include:

• - Unlawful Sharing of Health Data: It is alleged that Hims caredlessly transmitted user health information to third parties for advertising purposes, compromising consumer privacy rights.
• - Misleading Communication on Fees: The lawsuit claims that customers were charged for prescriptions shortly after submitting initial health assessments, despite assurances of medical consultations for appropriate treatments.
• - Regulatory Scrutiny: These actions exposed Hims to regulatory challenges, leading to potential fines and other penalties that investors were unaware of when they purchased shares.
• - False Business Valuations: The firm’s public claims regarding its operations and stability have been classified as misleading due to inadequate disclosure of regulatory issues that could financially impact the company.

The situation escalated when the Federal Trade Commission (FTC) initiated legal proceedings against Hims on July 29, 2026. This move brought to light an alleged pattern of 'deceptive and unlawful privacy practices,' culminating in a significant drop in Hims' stock price, which fell to $25.00 per share, reflecting a $4.32 decline (down 14.73%) that day.

What Can Affected Investors Do?

Affected investors have the opportunity to seek the lead plaintiff status in this class action. Those interested must act before the November 2, 2026 deadline. Here are the steps recommended:
1. Contact Kessler Topaz Meltzer & Check, LLP: This firm is facilitating discussions for eligible investors through their platform. They offer free consultations to assess your legal rights.
2. File for Lead Plaintiff Status: If you meet the criteria and want to take proactive legal action, ensure you submit your application before the deadline.
3. Stay Informed: Investors can choose to remain passive but still retain legal protections by merely being a member of the class.
4. Consult with Legal Experts: There is no upfront cost associated with the consultation services, as representation occurs on a contingency fee basis.

The Importance of Legal Representation

Having experienced attorneys like those at Kessler Topaz Meltzer & Check can make a substantial difference in navigating the complex securities fraud landscape. Their firm is recognized for successfully representing investors, recovering billions across numerous class actions. Past results, however, do not predict future outcomes but are nonetheless indicative of the firm’s commitment to investor rights.

Conclusion

Investors who are unsure of their eligibility or rights regarding this class action are strongly encouraged to seek legal counsel. For those who experienced losses in Hims & Hers Health, Inc. securities, this is an opportune moment to gain clarity and risk mitigation pathways. Protecting your investments is paramount, and legal recourse might be just the step you need to take in this tumultuous financial climate. For addition information, investors can reach out directly to attorney Jonathan Naji at Kessler Topaz Meltzer & Check, LLP. Act now to ensure your voice is heard in this critical financial matter.